Profile | GDS4284 / 233041_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1732.11 | 82 |
GSM687648 | Patient 402 control | 2310.56 | 85 |
GSM687653 | Patient 403 control | 2304.53 | 86 |
GSM687658 | Patient 404 control | 3825.47 | 91 |
GSM687663 | Patient 411 control | 4219.11 | 92 |
GSM687668 | Patient 422 control | 2389.89 | 86 |
GSM687673 | Patient 424 control | 3053.41 | 89 |
GSM687678 | Patient 425 control | 3442.16 | 90 |
GSM687683 | Patient 427 control | 3593.55 | 91 |
GSM687688 | Patient 428 control | 2863.13 | 88 |
GSM687695 | Patient 441 control | 1385.47 | 80 |
GSM687699 | Patient 443 control | 4293.74 | 92 |
GSM687704 | Patient 444 control | 5174.21 | 93 |
GSM687707 | Patient 448 control | 5802.45 | 94 |
GSM687712 | Patient 449 control | 2694.05 | 87 |
GSM687719 | Patient 450 control | 3103.71 | 89 |
GSM687724 | Patient 451 control | 3469.2 | 90 |
GSM687728 | Patient 452 control | 2286.87 | 86 |
GSM687646 | Patient 401 treated 24h | 3492.1 | 90 |
GSM687649 | Patient 402 treated 24h | 2106.88 | 84 |
GSM687665 | Patient 411 treated 24h | 2455.74 | 87 |
GSM687651 | Patient 402 treated 4 weeks | 3403.18 | 90 |
GSM687667 | Patient 411 treated 4 weeks | 2676.15 | 87 |
GSM687670 | Patient 422 treated 24h | 3121.97 | 89 |
GSM687671 | Patient 422 treated 4 weeks | 3112.55 | 89 |
GSM687654 | Patient 403 treated 24h | 2414.68 | 86 |
GSM687675 | Patient 424 treated 24h | 2651.29 | 88 |
GSM687685 | Patient 427 treated 24h | 2645.25 | 87 |
GSM687656 | Patient 403 treated 4 weeks | 2377.85 | 86 |
GSM687677 | Patient 424 treated 4 weeks | 5112.26 | 94 |
GSM687687 | Patient 427 treated 4 weeks | 3070.37 | 89 |
GSM687692 | Patient 428 treated 4h | 3196.93 | 89 |
GSM687716 | Patient 449 treated 4h | 4341.68 | 92 |
GSM687722 | Patient 450 treated 4h | 2347.29 | 86 |
GSM687680 | Patient 425 treated 24h | 2681.76 | 87 |
GSM687690 | Patient 428 treated 24h | 1938.32 | 84 |
GSM687700 | Patient 443 treated 24h | 1738.18 | 82 |
GSM687705 | Patient 444 treated 24h | 4372.08 | 92 |
GSM687714 | Patient 449 treated 24h | 2994.78 | 89 |
GSM687721 | Patient 450 treated 24h | 1450.92 | 80 |
GSM687682 | Patient 425 treated 4 weeks | 3572.92 | 90 |
GSM687694 | Patient 428 treated 4 weeks | 3616.78 | 90 |
GSM687702 | Patient 443 treated 4 weeks | 2960.42 | 89 |
GSM687718 | Patient 449 treated 4 weeks | 7527.82 | 96 |
GSM687723 | Patient 450 treated 4 weeks | 2412.85 | 86 |
GSM687661 | Patient 404 treated 4h | 3217.24 | 89 |
GSM687710 | Patient 448 treated 4h | 3524.28 | 90 |
GSM687726 | Patient 451 treated 4h | 4054.53 | 92 |
GSM687730 | Patient 452 treated 4h | 9329.82 | 97 |
GSM687660 | Patient 404 treated 24h | 1710.07 | 84 |
GSM687697 | Patient 441 treated 24h | 1731.98 | 83 |
GSM687709 | Patient 448 treated 24h | 4573.46 | 93 |
GSM687725 | Patient 451 treated 24h | 3832.66 | 91 |
GSM687729 | Patient 452 treated 24h | 1836.61 | 84 |
GSM687727 | Patient 451 treated 4 weeks | 5012.76 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 2789.94 | 88 |